NS
Nymbl Science, Inc.
SEC filingOther Health Care · Denver, CO
Amount raised$984Ksold at filing
Total offering$2.4M$1.4M still open
Investors in the raise30count reported to the SEC
FiledSep 12, 2025first sale Aug 29, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Thomas VirdenDirector
Ben WireDirector
Edward LikovichExecutive Officer, Director
Chris SaxmanDirector
Rohit SethDirector
Meghan OliverDirector
David EichlerDirector
Executive officers, directors and promoters as listed on the Form D.